Condition
Mycobacterium; Xenopi
Total Trials
1
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
Treatment Research
1 treatments under study, led by Standard Treatment
Research Leaders
20 sponsors active, led by Central Hospital Saint Quentin
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 1 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Phase 2 (1)
Trial Status
Recruiting1
Clinical Trials (1)
Showing 1 of 1 trials
Showing all 1 trials
Research Network
Common Treatments
- Standard Treatment1
Active Sponsors
- Central Hospital Saint Quentin1
- IHU Strasbourg1
- Centre Hospitalier Universitaire Amiens Picardie1
- CH Pontoise1
- CH Cannes1
Related Conditions
- Lung Diseases1
- Mycobacterium Xenopi Pulmonary Infection1